237 related articles for article (PubMed ID: 31731527)
1. Altilix
Castellino G; Nikolic D; Magán-Fernández A; Malfa GA; Chianetta R; Patti AM; Amato A; Montalto G; Toth PP; Banach M; Cicero AFG; Rizzo M
Nutrients; 2019 Oct; 11(11):. PubMed ID: 31731527
[TBL] [Abstract][Full Text] [Related]
2. A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study.
Terzo S; Amato A; Magán-Fernández A; Castellino G; Calvi P; Chianetta R; Giglio RV; Patti AM; Nikolic D; Firenze A; Mulè F; Ciaccio M; Rizzo M
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678333
[TBL] [Abstract][Full Text] [Related]
3. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
[TBL] [Abstract][Full Text] [Related]
4. Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial.
Mansour A; Mohajeri-Tehrani MR; Samadi M; Qorbani M; Merat S; Adibi H; Poustchi H; Hekmatdoost A
Nutr J; 2021 Apr; 20(1):35. PubMed ID: 33838673
[TBL] [Abstract][Full Text] [Related]
5. Carotid Extra-Media Thickness in Children: Relationships With Cardiometabolic Risk Factors and Endothelial Function.
Pacifico L; Perla FM; Tromba L; Carbotta G; Lavorato M; Pierimarchi P; Chiesa C
Front Endocrinol (Lausanne); 2020; 11():574216. PubMed ID: 33071981
[No Abstract] [Full Text] [Related]
6. Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.
Rizzo M; Rizvi AA; Patti AM; Nikolic D; Giglio RV; Castellino G; Li Volti G; Caprio M; Montalto G; Provenzano V; Genovese S; Ceriello A
Cardiovasc Diabetol; 2016 Dec; 15(1):162. PubMed ID: 27912784
[TBL] [Abstract][Full Text] [Related]
7. The effects of vitamin D supplementation on proatherogenic inflammatory markers and carotid intima media thickness in subjects with metabolic syndrome: a randomized double-blind placebo-controlled clinical trial.
Salekzamani S; Bavil AS; Mehralizadeh H; Jafarabadi MA; Ghezel A; Gargari BP
Endocrine; 2017 Jul; 57(1):51-59. PubMed ID: 28509078
[TBL] [Abstract][Full Text] [Related]
8. Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study.
Fresneda S; Abbate M; Busquets-Cortés C; López-González A; Fuster-Parra P; Bennasar-Veny M; Yáñez AM
Biol Sex Differ; 2022 Nov; 13(1):64. PubMed ID: 36333736
[TBL] [Abstract][Full Text] [Related]
9. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
Faghihzadeh F; Adibi P; Hekmatdoost A
Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
[TBL] [Abstract][Full Text] [Related]
10. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
[TBL] [Abstract][Full Text] [Related]
11. Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression.
Bhatia L; Scorletti E; Curzen N; Clough GF; Calder PC; Byrne CD
Atherosclerosis; 2016 Mar; 246():13-20. PubMed ID: 26748347
[TBL] [Abstract][Full Text] [Related]
12. Association of aortic stiffness, carotid intima-media thickness and endothelial function with cardiovascular events in metabolic syndrome subjects.
Ryliškytė L; Navickas R; Šerpytis P; Puronaitė R; Zupkauskienė J; Jucevičienė A; Badarienė J; Rimkienė MA; Ryliškienė K; Skiauterytė E; Laucevičius A
Blood Press; 2019 Apr; 28(2):131-138. PubMed ID: 30698025
[TBL] [Abstract][Full Text] [Related]
13. Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components.
Privitera G; Spadaro L; Alagona C; Calanna S; Piro S; Rabuazzo AM; Purrello F
Acta Diabetol; 2016 Jun; 53(3):449-59. PubMed ID: 26496770
[TBL] [Abstract][Full Text] [Related]
14. A randomised placebo controlled trial of VSL#3
Chong PL; Laight D; Aspinall RJ; Higginson A; Cummings MH
BMC Gastroenterol; 2021 Apr; 21(1):144. PubMed ID: 33794784
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids.
Spahis S; Alvarez F; Ahmed N; Dubois J; Jalbout R; Paganelli M; Grzywacz K; Delvin E; Peretti N; Levy E
J Nutr Biochem; 2018 Aug; 58():28-36. PubMed ID: 29864682
[TBL] [Abstract][Full Text] [Related]
16. Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease.
Pervez MA; Khan DA; Ijaz A; Khan S
Turk J Gastroenterol; 2018 Mar; 29(2):170-176. PubMed ID: 29749323
[TBL] [Abstract][Full Text] [Related]
17. Magnesium-zinc-calcium-vitamin D co-supplementation improves glycemic control and markers of cardiometabolic risk in gestational diabetes: a randomized, double-blind, placebo-controlled trial.
Karamali M; Bahramimoghadam S; Sharifzadeh F; Asemi Z
Appl Physiol Nutr Metab; 2018 Jun; 43(6):565-570. PubMed ID: 29316405
[TBL] [Abstract][Full Text] [Related]
18. Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients With Metabolic Syndrome.
Patti AM; Al-Rasadi K; Katsiki N; Banerjee Y; Nikolic D; Vanella L; Giglio RV; Giannone VA; Montalto G; Rizzo M
Angiology; 2015 Oct; 66(9):856-61. PubMed ID: 25632052
[TBL] [Abstract][Full Text] [Related]
19. Effect of high-dose vitamin D supplementation on cardiometabolic risk factors in subjects with metabolic syndrome: a randomized controlled double-blind clinical trial.
Salekzamani S; Mehralizadeh H; Ghezel A; Salekzamani Y; Jafarabadi MA; Bavil AS; Gargari BP
J Endocrinol Invest; 2016 Nov; 39(11):1303-1313. PubMed ID: 27400997
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Folate Supplementation on Carotid Intima-Media Thickness and Metabolic Status in Patients with Metabolic Syndrome.
Talari HR; Rafiee M; Farrokhian A; Raygan F; Bahmani F; Darooghegi Mofrad M; Hamidian Y; Tamtaji OR; Karamali F; Asemi Z
Ann Nutr Metab; 2016; 69(1):41-50. PubMed ID: 27450552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
